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Challenges relating to comparison of flavonoid glycosides 
dissolution profiles from Sutherlandia frutescens products
Unlike the case of conventional drug formulations, dissolu-
tion tests have hitherto not been required for herbal me-
dicinal products commercially available in South Africa. 
This study investigated dissolution of the South African 
Sutherlandia frutescens using selected flavonoid glycosides 
as marker compounds. Dissolution of markers was as-
sessed in three dissolution media at pH 1.2, 4.5 and 6.8, and 
samples were analysed using a validated HPLC method. 
The dissolution profile of each marker varied for the differ-
ent materials investigated. All three media utilised showed 
differences in flavonoid glycoside dissolution between the 
S. frutescens products evaluated, with f2 values < 50 for com-
parison of flavonoid dissolution from any two of the mate-
rials. Dissolution of S. frutescens materials could thus be 
characterised using the markers in all the media tested. 
This tool may be employed in the future for comparison of 
orally administered S. frutescens products, provided be-
tween-batch variability is evaluated and found less than 
between-sample variability.
Keywords: Sutherlandia frutescens, herbal products, dissolu-
tion testing, flavonoid, discriminatory medium, similarity 
factor
There is a global need for regulation and quality assurance of herbal medicinal prod-
ucts (1). In general, the tools and experience to effectively meet this need are lacking espe-
cially in many developing countries. This also applies to popular and widely used indig-
enous South African herbal medicinal products such as Sutherlandia frutescens. It is 
traditionally reputed to be a cure for many ailments, and some of its claimed pharmaco-
logical effects have been proven by in vitro tests (2). It has recently gained renewed interest 
due to reports from patients and proponents of herbal medicine therapy on its activity 
against HIV, and concerns regarding interactions when co-administered with antiretrovi-
ral drugs (2, 3). Consequently, arrangements are underway for a phase I pharmacokinetic 
study to assess the bioavailability of S. frutescens products. In such studies, S. frutescens 
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products of established and consistent pharmaceutical quality would be required. One 
such quality is the release of its active constituents in dissolution tests, for which a dis-
criminatory medium and appropriate marker compounds should be employed.
Flavonoids have been reported as constituents of S. frutescens (4) and may contribute 
to the activity of this plant medicine (2). In S. frutescens, flavonoid glycosides (sutherlandins 
A, B, C and D) of the aglycones, quercetin and kaempferol, have been reported as possible 
chemical markers (4), and may serve as suitable references for comparison and in vitro dis-
solution tests.
Crucial to mention though is the fact that selection of marker compounds for dissolu-
tion tests or otherwise of herbal materials such as S. frutescens will pose challenges. Firstly, 
unlike conventional drug formulations where activity is attributed to a single known and 
well researched compound, herbal medicinal products (HMPs) are made up of multiple 
components, some of which may not have a direct effect on pharmacological properties of 
the product. Secondly, the ratio of these different constituents may vary according to cul-
tivation, harvesting or processing methods, influencing the in vitro release and hence ef-
ficacy of the compound (5). While rigorous quality control tests may not be required for 
HMPs, because they may be classified as dietary supplements and not as drugs, efforts are 
made to improve the quality of such products in many countries such as South Africa and 
Croatia, to mention just a few (6, 7). Such quality improvement measures may involve dis-
solution studies for comparison of products. Thus far, no method has been documented 
for the evaluation of in vitro dissolution profiles of S. frutescens products.
In this study, a simple modified pharmacopoeial dissolution method is employed for 
S. frutescens products. The results from this study are discussed within the context of dif-
ferentiation between materials of the popular S. frutescens.
EXPERIMENTAL
Reagents and samples
Samples of S. frutescens leaf powder (LP, batch number: BN E16794; Afriplex, Paarl, 
South Africa), spray-dried aqueous extract 1 (SDAE 1; batch number: Ferl-DST/001-1210, 
South Africa), and spray-dried aqueous extract 2 (SDAE 2, batch number: 1674; Ferlot Manu-
facturing & Packaging Pty Ltd, South Africa) were used. Their flavonoid glycosides 
(sutherlandins A, B, C and D), not commercially available, were isolated from the n-buta-
nol soluble portion of the ethyl acetate extract of S. frutescens spray-dried aqueous extract 
(SDAE) material. The butanol extract was subjected to reversed phase column chromatog-
raphy using solid phase extraction (SPE) cartridges for the isolation of flavonoid fractions, 
from which flavonoid glycoside compounds were isolated. Acetonitrile (HPLC grade) was 
from Sigma Aldrich, while formic acid (analytical grade) and concentrated hydrochloric 
acid (analytical grade) were from Merck. All water used was obtained from an in-house 
Milli-Q purification system (Millipore, USA).
Instrumentation
Dissolution tests were conducted using the USP basket-type apparatus (VanKel VK 
700, USA) at 37 ± 0.5 °C. Stainless steel baskets of size 40 were used, and the baskets were 
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rotated at 100 revolutions per minute. Analysis of marker compounds in dissolution media 
was conducted using a validated HPLC method on an Agilent 1200 series HPLC system 
equipped with an in-line degassing system, quaternary pump, auto-loading sampler, ther-
mostatted column compartment and photodiode array detector.
Chromatographic conditions
Analysis of marker compounds in dissolution media was conducted using an Agilent 
1200 series HPLC system equipped with an in-line degassing system, quaternary pump, 
auto-loading sampler, thermostatted column compartment and photodiode array detector, 
as previously described (8). Chromatographic separation was obtained on a Phenomenex 
Luna® C18 column (25 cm × 4.6 mm, 5 µm i.d.) with a compatible guard column, both main-
tained at 45 °C. The mobile phase consisted of water (0.01 % formic acid) (A) and acetoni-
trile (0.01 % formic acid) (B), filtered and degassed prior to use. The flow rate of the mobile 
phase was maintained at 0.8 mL min–1, injection volume was 20 µL, and peaks were sepa-
rated by gradient elution: 0 to 1 min, 82 % A/18 % B; 1 to 15 min, 82 % A/18 % B to 75 % A/25 
% B; 15 to 20 min, 75 % A/25 % B to 65 % A/35 % B; 20 to 25 min, 65 % A/35 % B to 40 % A/ 
60 % B; 25 to 26 min, 40 % A/60 % B to 82 % A/18 % B, followed by equilibration with 82 % 
A/18 % B from 26 to 35 minutes. The eluent was monitored at several wavelengths over a 
range from 250 to 380 nm; the specific wavelength of interest was 370 nm. Data acquisition 
and processing were accomplished using the OpenLAB™ CDS ChemStation Edition soft-
ware.
Encapsulation of S. frutescens materials
The S. frutescens materials used (LP, SDAE 1 and SDAE 2) were filled into size 0 cap-
sules using a Cap-M-Quik™ capsule filler (S L Sanderson & Co., Berry Creek, CA, USA). 
Capsules were weighed before and after filling in order to calculate the weight of the en-
capsulated material and assess variation.
Validation of dissolution method
The dissolution test used in this study is classified as a category III procedure (i.e., 
analytical procedure for determination of performance characteristics); hence the need to 
evaluate its precision by repeatability (9). Six replicate samples, containing the SDAE 1 
material, were collected from six vessels of the dissolution apparatus (at pH 1.2) at a 
60-minute sampling time. The samples were analysed to validate method precision, and 
the values were expressed as relative standard deviation (% RSD) between samples.
Dissolution conditions
In line with dissolution guidelines for new products, dissolution tests were conducted 
in three dissolution media at pH 1.2, 4.5 and 6.8, all maintained at 37 ± 0.5 °C (10). Although 
the dissolution medium volume of 900 mL is commonly used in dissolution tests, reduction 
of this volume may be advocated in cases where the label claim is less than 5 mg (11). Due to 
the low level of marker compounds in the S. frutescens materials studied (i.e. < 5 mg/capsule), 
the official dissolution conditions were modified to 450 mL of dissolution medium for each 
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vessel. In each of the twelve replicate vessels of the dissolution apparatus containing the 
appropriate dissolution medium at either pH 1.2, 4.5 or 6.8, two capsules containing the S. 
frutescens product to be evaluated were introduced into mesh baskets used to retain the 
capsules and the baskets were rotated at 100 revolutions per minute (rpm). At predetermined 
time intervals (5, 10, 15, 20, 30, 60, 90 and 120 minutes), 3 mL of sample was withdrawn from 
each vessel through a 0.45 micron nylon membrane and replaced with an equal volume of 
the same pre-warmed medium in order to maintain a constant volume.
Data analysis
Withdrawn samples were analysed using a validated HPLC method. The amount of 
each marker (flavonoid glycoside) compound dissolved at specified sampling times was cal-
culated from the peak areas of the HPLC chromatograms. Cumulative percentage released 
was calculated from the ratio of the quantified amount to the average flavonoid content in 
capsules. Data was plotted as percentage dissolved ± standard deviation (SD) vs. sample dis-
solution time. Dissolution profiles were compared using the similarity factor, f2 (12).
RESULTS AND DISCUSSION
Following encapsulation, the masses obtained for the encapsulated LP, SDAE 1 and 
SDAE 2 materials were 322.5 ± 8.7, 324.9 ± 7.6 and 414.8 ± 9.1 mg (mean ± SD), respectively.
The dissolution method precision validation returned values of 4.4, 4.8, 2.7 and 17.0 % 
for sutherlandins A, B, C and D, respectively. Dissolution profiles of the assessed flavo-
noids from S. frutescens LP, SDAE 1 and SDAE 2 are presented in Fig. 1 to 4. The figures 
show the release of each sutherlandin from S. frutescens LP, SDAE 1 and SDAE 2 under 
three different pH conditions: 1.2, 4.5 and 6.8. Table I shows the f2 values for comparison of 
flavonoid dissolution from the S. frutescens LP, SDAE 1 and SDAE 2 materials.
Fig. 1. Dissolution profiles of sutherlandin A from S. frutescens products at pH 1.2, 4.5 and 6.8 (mean 
± SD). LP – leaf powder, SDAE – spray-dried aqueous extract.
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Fig. 2. Dissolution profiles of sutherlandin B from S. frutescens products at pH 1.2, 4.5 and 6.8 (mean ± 
SD). LP – leaf powder, SDAE – spray-dried aqueous extract.
Fig. 3. Dissolution profiles of sutherlandin C from S. frutescens products at pH 1.2, 4.5 and 6.8 (mean 
± SD). LP – leaf powder, SDAE – spray-dried aqueous extract.
Masses obtained for the encapsulated LP, SDAE 1 and SDAE 2 materials were 322.5 ± 8.7, 
324.9 ± 7.6 and 414.8 ± 9.1 mg (mean ± SD), respectively. This complied with the pharma-
copoeial requirements for weight uniformity, i.e., between 85 and 115 % of the mean.
The dissolution method showed precision for the quantification of three out of four 
flavonoid glycosides (sutherlandins A, B and C) calculated from samples withdrawn from 
the dissolution medium (at pH 1.2) at the 60-minute sampling time. The % RSD values for 
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sutherlandins A, B and C were 4.4, 4.8 and 2.7 %, respectively, all within the specified 
criterion of ≤ 5 % (9). This suggests that the dissolution method described herein is precise 
for the analysis of sutherlandins A, B and C from the different S. frutescens materials. The 
% RSD for sutherlandin D was however 17.0 %, outside the specification limits, possibly 
due to degradation of this marker compound at different rates in the different vessels con-
taining an acidic dissolution medium. This may imply that sutherlandin D may not be a 
good marker compound for the analysis of S. frutescens plant materials at pH 1.2. However, 
such conclusions cannot be drawn regarding its suitability at pH 4.5 and 6.8 (or in any 
other suitable dissolution medium). In addition, the fact that sutherlandins A, B and C 
seem suitable for dissolution profile comparison at pH 1.2 does not imply that they are 
suitable for dissolution tests in other suitable dissolution media. Any inference regarding 
the suitability of any marker in any medium may only be drawn when suitable validation 
tests are performed in advance.
Perusal of Figs. 1 to 4 shows that dissolution of sutherlandins A, B, C and D from all 
three assessed products varied from delayed to rapidly dissolving. From the LP products 
under all three pH conditions, none of the marker compounds displayed the characteristic 
of immediate release (i.e., at least 75 % dissolved within 45 minutes). From SDAE 2 under 
all three pH conditions, all the marker compounds (except sutherlandin C at pH 1.2) dis-
played a lag time of at least 10 minutes prior to dissolution. In all three media tested, dis-
solution from SDAE 1 was the fastest while dissolution from SDAE 2 was the slowest.
With respect to origin, the LP product consists of small bits of aerial S. frutescens plant 
materials, from which SDAE 1 and SDAE 2 products were made (not necessarily the same 
LP batch investigated here). Being aqueous extracts, it was presumed that dissolution rates 
of the sutherlandins from SDAE 1 and SDAE 2 would be faster than from LP. The results 
(Figs. 1 to 4) however show faster marker compound dissolution from LP and SDAE 1 
products compared to SDAE 2. It seems that the aqueous extract nature of SDAE 2 was not 
Fig. 4. Dissolution profiles of sutherlandin D from S. frutescens products at pH 1.2, 4.5 and 6.8 (mean 
± SD). LP – leaf powder, SDAE – spray-dried aqueous extract.
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sufficient to hasten flavonoid glycoside dissolution from this product when compared to 
LP. The LP, though not an aqueous extract, exhibited faster dissolution than SDAE 2. Some 
other characteristic over-riding its non-aqueous nature may have contributed to such an 
effect. Previous studies have reported the presence of polysaccharides in S. frutescens 
leaves (13), and so further testing of the three S. frutescens products for sugars and starch 
were conducted using Benedict’s and iodine tests, respectively. The presence of starch was 
detected in SDAE 2. While starch is generally used as a disintegrant in solid dose formula-
tions, it may also serve as a binder or anti-adherent and, in such cases, may retard marker 
compound dissolution from a product. This may account for the slower dissolution of 
sutherlandins from SDAE 2. The LP and SDAE 1 materials did not test positive for starch; 
however, the presence of sugars was noted (assessed by precipitate formation and colour), 
more concentrated in the LP material than in aqueous extracts. This could account for the 
faster dissolution of LP compared to SDAE 2. SDAE 2 is considered an older product than 
SDAE 1 (i.e., SDAE 2 was produced earlier than SDAE 1). Is there perhaps a possibility that 
the ‘unprocessed’ and more recently processed S. frutescens materials (e.g., LP or SDAE 1) 
contain more sugar and little or no starch, with the sugar converted to starch over time? 
Could this explain why the more recent batches contained traces of simple sugar and no 
starch while the older product (SDAE 2) contained more starch? However, no confirmation 
of this has been found in literature.
At pH values of 4.5 and 6.8, all the flavonoid glycosides displayed immediate release 
characteristics from SDAE 1. At pH 1.2, however, only sutherlandins A and C from SDAE 
1 displayed such characteristics. Dissolution of sutherlandins B and D from SDAE 1 at pH 
1.2 was much slower than that obtained for sutherlandins A and C. For sutherlandins B 
and D from SDAE 1 at pH 1.2, the dissolution curve of these marker compounds displayed 
a downward trend after attaining maximum dissolution, while this was not the case of 
sutherlandins A and C. Sutherlandins B and D are different in that they are flavonoid 
glycosides of the aglycones, quercetin and kaempferol, respectively, while the presence of 
the apiofuranosyl group is a similarity (4). It is very likely that the observed decrease in 
percentage dissolved after peak dissolution (for sutherlandins B and D) may be caused by 
degradation of the flavonoid glcycoside, possibly attributable to the glycoside component 
of the compound. Likewise, sutherlandins A and C are different in that they are flavonoid 
glycosides of the aglycones, quercetin and kaempferol, respectively, while the presence of 
the xylopyranosyl group is a similarity (4). It is also very likely that the resistance of suther-
landins A and C to breakdown in the dissolution medium at pH 1.2 can be attributed to 
this similarity – the xylopyranosyl group. The downward trend in dissolution profiles of 
sutherlandins B and D at pH 1.2 was not obtained under other pH conditions or from the 
LP and SDAE 2 materials. It seems that while the sugar moiety in sutherlandins B and D 
may make them prone to degradation at pH 1.2, resulting in a decrease in the cumulative 
amount of sutherlandins B and D dissolved over time, the SDAE 1 material also provided 
an enabling environment for this to occur.
Comparison of dissolution profiles for each marker compound of any two of the three 
S. frutescens products using the similarity factor gave values lower than 50 in all cases 
(Table I).
This implies dissimilarity of the assessed dissolution profiles. However, the variances 
obtained with the dissolution data for flavonoid glycosides were beyond the limits stipu-
lated for the f2 equation (i.e., % CV < 20 % for earlier time points and < 10 % for later time 
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points), which may be due to the inherent variability of natural products (14). Extensive 
between-batch variations of the tested products may result in the overlap of dissolution 
profiles from the tested batches, returning erroneous values for dissolution profile com-
Table I. Comparison of f2-values for sutherlandin dissolution profiles at pH 1.2, 4.5 and 6.8
Sutherlandin A Sutherlandin B
a) LP vs. SDAE materials a) LP vs. SDAE materials
pH f2 wt f2 pH f2 wt f2
1.2 17.2 4.9 1.2 36.3 17
4.5 16 3.3 4.5 12.9 –2.5
6.8 17.5 4.6 6.8 12.9 –2.2
    
b) LP vs. FDAE materials b) LP vs. FDAE materials
pH f2 wt f2 pH f2 wt f2
1.2 32.1 9.4 1.2 34.6 21.3
4.5 28.8 4.6 4.5 34.1 12.9
6.8 27.5 11 6.8 33.7 9.6
    
c) SDAE vs. FDAE materials a) SDAE vs. FDAE materials
pH f2 wt f2 pH f2 wt f2
1.2 9.2 –11 1.2 21.5 6.5
4.5 8.9 –16.3 4.5 9.5 –14.6
6.8 8.5 –6.5 6.8 7.9 15.1
Sutherlandin C Sutherlandin D
a) LP vs. SDAE materials a) LP vs. SDAE materials 
pH f2 wt f2 pH f2 wt f2
1.2 9.2 –3.0 1.2 48.9 28.1
4.5 15.6 2.9 4.5 15 0.6
6.8 18.5 6 6.8 19.6 5.7
    
b) LP vs. FDAE materials b) LP vs. FDAE materials
pH f2 wt f2 pH f2 wt f2
1.2 30.8 15.8 1.2 35.8 5.7
4.5 30.9 9.1 4.5 31.2 8.7
6.8 26.7 3.5 6.8 26.6 –3.3
    
c) SDAE vs. FDAE materials c) SDAE vs. FDAE materials
pH f2 wt f2 pH f2 wt f2
1.2 5.2 –10.5 1.2 30 0.3
4.5 8.6 –13.8 4.5 8.3 –14.4
6.8 7.7 –14.0 6.8 8.3 –20.6
f2 – original similarity factor; wt f2 – similarity factor modified to allow for the impact of within-batch variability on f2
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parison. It may therefore be necessary to evaluate such between-batch variability prior to 
assessing different products in order to show that tested products can be distinguished 
even if different batches of respective products are used.
To address extensive within-batch variation, which may introduce errors during com-
parison, dissolution profiles may also be compared using a modification of the original 
similarity factor proposed by Gohel et al. (15) (Table I, wt f2). This modification of the simi-
larity factor, unlike the original f2 formula, incorporates a weighting scheme to accommo-
date for within-batch variations, and is thought to result in a more discriminating value 
for dissolution profile comparison of samples with extensive variation. A more discrimi-
nating method for dissolution profile comparison in this study is defined as one with a 
lower f2 value.
Further comparisons of sutherlandins A, B, C and D dissolution profiles using the 
modified f2 equation all gave values below 50, further confirming dissimilarity of dissolu-
tion profiles (Table I). In all comparison scenarios, Gohel’s modified similarity factor (wt f2, 
Table I) proved to be a more discriminating tool for dissolution profile comparison, since 
it returned the lowest f2 values. The wt f2 values were also significantly different from the 
original f2 values (p < 0.001). Dissolution of the aglycones, quercetin and kaempferol, 
though detected from some products and under some pH conditions, could not be quanti-
fied. This may be due to their very low content in the S. frutescens products (0 to 0.26 %).
A suitable dissolution test should be able to differentiate between products that have 
been modified via formulation or process changes, though such modifications may be 
subtle. The findings from our study indicate that the dissolution test reported herein can 
be used to differentiate between the S. frutescens products studied. For the test, flavonoid 
glycosides were found to be better marker and differentiating compounds than flavonoid 
aglycones for dissolution studies of S. frutescens materials; they were detected in the differ-
ent dissolution media and also projected different dissolution properties for different S. 
frutescens materials. Glycosylation of a flavonoid decreases its reactivity while improving 
its water solubility (16), enhancing its dissolution in water-based media. This may serve to 
explain the detection of flavonoid glycosides, to different degrees, in the dissolution media 
assessed. This may also be due to the content of the flavonoid glycoside, which is more 
than that of the flavonoid aglycones in water-based extracts of the different products.Dis-
solution testing of S. frutescens materials therefore enabled release of flavonoid glycosides 
in the three dissolution media tested, and each of the three media could be used to dif-
ferentiate between the S. frutescens materials studied. In acidic medium (at pH 1.2), how-
ever, it may be preferable to employ only sutherlandins A and C as marker compounds. 
Their dissolution profiles were not adversely affected by acidic pH, and no breakdown of 
these compounds was noticed in any of the dissolution media assessed.
Dissolution characteristics of each flavonoid compound from the different S. frutescens 
materials show that the same flavonoid glycoside may not necessarily be released from 
different materials at the same rate. This may be due to the differences in their release 
mechanisms from different materials, which is currently under investigation. Such differ-
ences may also translate to differences in in vivo bioavailability of flavonoid compounds 
from the different materials.
It is crucial to mention that whilst flavonoid glycosides have been identified in S. fru-
tescens as potential marker compounds, and display some properties associated with its 
potential medicinal activities, there is as yet no clear indication that they are the major 
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active components. Therefore, although their dissolution profiles will provide a means of 
comparing extracts, changes in dissolution profiles may not necessarily reflect the efficacy 
of a given extract.
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